Search details
1.
Serum immunoglobulin G and mucosal immunoglobulin A antibodies from prepandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro.
Int J Infect Dis
; 127: 11-16, 2023 Feb.
Article
in English
| MEDLINE | ID: mdl-36476349
2.
SARS-CoV-2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February-December 2022.
Influenza Other Respir Viruses
; 17(9): e13173, 2023 Sep.
Article
in English
| MEDLINE | ID: mdl-37752065
3.
Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial.
Wellcome Open Res
; 8: 182, 2023.
Article
in English
| MEDLINE | ID: mdl-38707489
4.
Comparative performance of WANTAI ELISA for total immunoglobulin to receptor binding protein and an ELISA for IgG to spike protein in detecting SARS-CoV-2 antibodies in Kenyan populations.
J Clin Virol
; 146: 105061, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34973474
5.
Epidemiology of COVID-19 infections on routine polymerase chain reaction (PCR) and serology testing in Coastal Kenya.
Wellcome Open Res
; 7: 69, 2022.
Article
in English
| MEDLINE | ID: mdl-35505772
6.
SARS-CoV-2 seroprevalence in three Kenyan health and demographic surveillance sites, December 2020-May 2021.
PLOS Glob Public Health
; 2(8): e0000883, 2022.
Article
in English
| MEDLINE | ID: mdl-36962821
Results
1 -
6
de 6
1
Next >
>>